The National Times - From rations to G20's doorstep: Poland savours economic 'miracle'

From rations to G20's doorstep: Poland savours economic 'miracle'


From rations to G20's doorstep: Poland savours economic 'miracle'
From rations to G20's doorstep: Poland savours economic 'miracle' / Photo: © AFP

Many Poles scoffed in 1980 when Lech Walesa, leader of the nascent Solidarity union, promised that Poland would become "a second Japan" -- yet the country now finds itself primed to join the G20 club of major economies.

Change text size:

Since the fall of communism 35 years ago, Poland has transformed itself from a command economy notorious for rationed goods and empty store shelves to one of the engines of European growth.

With a GDP of around $1 trillion, Poland now has the 20th largest economy in the world, surpassing those of Sweden, Switzerland or Taiwan.

When adjusted for purchasing power, its per capita GDP will exceed Japan's this year and reach 80 percent of the European average, according to the IMF and Eurostat.

"For my generation, it's a huge achievement; for my parents' generation, it's a miracle," Finance Minister Andrzej Domanski said recently.

This year the Polish economy is widely expected to surpass the government's 3.4 percent growth target, making it one of the best performers in the EU, and the jobless rate is down to just over three percent.

That performance has gotten the attention of Washington, which has invited Warsaw to attend the G20 summit it is hosting in Miami next December, after excluding South Africa over a diplomatic spat.

"Poland, a nation that was once trapped behind the Iron Curtain but now ranks among the world's 20 largest economies, will be joining us to assume its rightful place in the G20," Secretary of State Marco Rubio said in December.

- More than catching up -

Poland's recognition on the world stage has become a source of pride for many Poles, who entered the 1990s with a strong desire to "catch up with the West," according to Maciej Witucki, head of the country's Lewiathan business association.

Around 67 percent of Poles report being satisfied with their material situation, a record high, according to a CBOS poll in late December.

"Today, not only are we catching up with the West, but we have surpassed it in many aspects of daily life," Witucki said, not far from gleaming skyscrapers and a new site for the Warsaw Museum of Modern Art, designed by US architect Thomas Phifer.

"In France, in thirty years, the only thing that has changed is the prices, now in euros and no longer in francs," he added. "In Warsaw, everything evolves every two or three years."

For Bastien Loiseau, a French-Polish filmmaker who has lived in Warsaw for the past twenty years, Poland's massive transformations are a part of daily life.

The country boasts a modern highway network, efficient public transportation, widespread high-speed internet, and safety and cleanliness in public spaces.

"Compared to France, a country that is difficult to change, Poland is changing enormously," Loiseau said.

Jean Rossi, a French business lawyer who has long been based in Poland, said he believed that "this miracle is primarily due to the Poles themselves".

Beyond a solid education system, he praised a widespread belief that "they cannot rely on the state at all".

The country has however relied on EU funds to help modernise the country since joining the bloc in 2004, and is set to be the largest recipient of EU funds in the bloc's 2028-34 budget, receiving 123 billion euros ($145 billion).

"Poland has made extremely good use of European funds, both for its infrastructure and for industry," Witucki said, with small and midsize companies benefiting in particular.

- No one left to work? -

The optimistic picture is not without warning signs, as economists point to increased social spending as a growing burden on public finances, and the war in neighbouring Ukraine as a deterrent to future investments.

The main challenge, however, is Poland's birth rate, which has fallen below the EU average to 1.1 children per woman, according to the country's statistics agency.

Despite generous maternal leave and social programs for families, the agency says the population could shrink to 30 million people by 2060 from around 38 million now.

"There won't be anyone left to work," said Rossi, noting that a reluctance to let in Ukrainians due to rising anti-immigrant sentiment could be counterproductive.

Experts also point to a low level of innovation and research spending, among the lowest in the EU, and relatively low pay for scientists, contributing to a "brain drain".

But Rossi, like many others, remains optimistic, noting high-profile projects in the works including nuclear power plants and high-speed trains, and a burgeoning space industry.

"You can't do everything at once. First, they had to build the infrastructure; now that that's done, they'll focus on research and development," he said.

F.Adams--TNT

Featured

Carney touts Canada 'pivot' away from US as Trump levels new threat

Canadian Prime Minister Mark Carney said Tuesday that reducing economic ties with the United States would come at a cost but the benefits were clear, as President Donald Trump threatened new penalties targeting Canada.

Nearly 1,100 flights cancelled after UK air traffic control glitch

Almost 1,100 flights to and from UK airports were cancelled Tuesday due to what the country's air traffic control service called a technical issue, in the latest glitch to spark travel chaos.

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Change text size: